ATE136650T1 - Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür - Google Patents

Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür

Info

Publication number
ATE136650T1
ATE136650T1 AT90915180T AT90915180T ATE136650T1 AT E136650 T1 ATE136650 T1 AT E136650T1 AT 90915180 T AT90915180 T AT 90915180T AT 90915180 T AT90915180 T AT 90915180T AT E136650 T1 ATE136650 T1 AT E136650T1
Authority
AT
Austria
Prior art keywords
dvma
vma
antibody
reaction
acid
Prior art date
Application number
AT90915180T
Other languages
English (en)
Inventor
Manami Kuroda
Masahito Sugi
Original Assignee
Yamasa Shoyu Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu Kk filed Critical Yamasa Shoyu Kk
Application granted granted Critical
Publication of ATE136650T1 publication Critical patent/ATE136650T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Peptides Or Proteins (AREA)
AT90915180T 1989-10-19 1990-10-18 Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür ATE136650T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27253889 1989-10-19

Publications (1)

Publication Number Publication Date
ATE136650T1 true ATE136650T1 (de) 1996-04-15

Family

ID=17515291

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90915180T ATE136650T1 (de) 1989-10-19 1990-10-18 Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür

Country Status (8)

Country Link
US (1) US5298397A (de)
EP (1) EP0450095B1 (de)
JP (1) JPH0782015B2 (de)
AT (1) ATE136650T1 (de)
AU (1) AU638500B2 (de)
CA (1) CA2044154C (de)
DE (1) DE69026497T2 (de)
WO (1) WO1991006005A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002097040A2 (en) * 2001-05-30 2002-12-05 Paradigm Genetics, Inc. Methods for the identification of inhibitors of pectin esterase expression or activity in plants
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
CN105175530A (zh) * 2015-08-14 2015-12-23 苏州博源医疗科技有限公司 一种香草扁桃酸免疫检测试剂及其制备方法
CN107353200A (zh) * 2017-06-27 2017-11-17 苏州博源医疗科技有限公司 一种香草扁桃酸衍生物、其合成方法及一种香草扁桃酸免疫原、其制备方法及其应用
CN114956997B (zh) * 2022-03-30 2022-12-16 北京丹大生物技术有限公司 香草扁桃酸半抗原衍生物及其合成方法，香草扁桃酸抗原及其制备方法，抗体及试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123765A (ja) * 1983-12-07 1985-07-02 Yamaguchiken バニルマンデリック酸に対する特異抗体の製造方法
JPH061271B2 (ja) * 1985-02-27 1994-01-05 ヤマサ醤油株式会社 カテコ−ルアミンの酸性代謝物に対する抗体の製造法およびそれに使用する抗原

Also Published As

Publication number Publication date
WO1991006005A1 (en) 1991-05-02
DE69026497T2 (de) 1996-08-22
US5298397A (en) 1994-03-29
DE69026497D1 (de) 1996-05-15
EP0450095A1 (de) 1991-10-09
CA2044154A1 (en) 1991-04-20
AU638500B2 (en) 1993-07-01
EP0450095B1 (de) 1996-04-10
EP0450095A4 (de) 1991-08-07
JPH0782015B2 (ja) 1995-09-06
AU6532390A (en) 1991-05-16
CA2044154C (en) 1999-07-13

Similar Documents

Publication Publication Date Title
ATE113723T1 (de) Verfahren zur bestimmung von antikörpern.
ATE297950T1 (de) Testverfahren und reagenzien zur quantifizierung von hbnp
NO903124L (no) Testmetode og reagenssett for denne.
ATE58600T1 (de) Testverfahren.
ATE91023T1 (de) Verfahren und vorrichtungen zur durchfuehrung von untersuchungen.
DE3577230D1 (de) Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer.
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
DK314987D0 (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
ATE333091T1 (de) Verfahren zur messung von blutersatzstoffen
ATE111533T1 (de) Verfahren zur bestimmung von nukleinsäuren.
DE68924243D1 (de) Verfahren und Reagenzien zum Nachweis von Amphetamin und/oder d-Methamphetamin in biologischen Proben.
ATE136650T1 (de) Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
ATE145480T1 (de) Verfahren zur bestimmung eines analyten
ATE88571T1 (de) Immunologischer testkit.
DE3669078D1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ATE146595T1 (de) Verfahren zur bestimmung einer immunologisch bindefähigen substanz
KR880700270A (ko) 검체의 발광을 이용하여 검체가 존재가능한 매질에서 검체를 검출 및/또는 측정하기 위한 단상 방법
ES2036189T3 (es) Un metodo para efectuar un inmunoensayo de diagnostico.
ATE150177T1 (de) Verfahren zur bestimmung von autoantikörpern in biologischen flüssigkeiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties